The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations

Distinct metabolic effects of two fat compartments

Miriam Cnop, Melinda J. Landchild, Josep Vidal, Peter J Havel, Negar G. Knowles, Darcy R. Carr, Feng Wang, Rebecca L. Hull, Edward J. Boyko, Barbara M. Retzlaff, Carolyn E. Walden, Robert H. Knopp, Steven E. Kahn

Research output: Contribution to journalArticle

300 Citations (Scopus)

Abstract

Obesity is associated with insulin resistance, particularly when body fat has a central distribution. However, insulin resistance also frequently occurs in apparently lean individuals. It has been proposed that these lean insulin-resistant individuals have greater amounts of body fat than lean insulin-sensitive subjects. Alternatively, their body fat distribution may be different. Obesity is associated with elevated plasma leptin levels, but some studies have suggested that insulin sensitivity is an additional determinant of circulating leptin concentrations. To examine how body fat distribution contributes to insulin sensitivity and how these variables are related to leptin levels, we studied 174 individuals (73 men, 101 women), a priori classified as lean insulin-sensitive (LIS, n = 56), lean insulin-resistant (LIR, n = 61), and obese insulin-resistant (OIR, n = 57) based on their BMI and insulin sensitivity index (SI). Whereas the BMI of the two lean groups did not differ, the SI of the LIR subjects was less than half that of the LIS group. The subcutaneous and intra-abdominal fat areas, determined by computed tomography, were 45 and 70% greater in the LIR subjects (P < 0.001) and 2.5- and 3-fold greater in the OIR group, as compared with the LIS group. Fasting plasma leptin levels were moderately increased in LIR subjects (10.8 ± 7.1 vs. 8.1 ± 6.4 ng/ml in LIS subjects; P < 0.001) and doubled in OIR subjects (21.9 ± 15.5 ng/ml; P < 0.001). Because of the confounding effect of body fat, we examined the relationships between adiposity, insulin sensitivity, and leptin concentrations by multiple regression analysis. Intraabdominal fat was the best variable predicting insulin sensitivity in both genders and explained 54% of the variance in SI. This inverse relationship was nonlinear (r = -0.688). On the other hand, in both genders, fasting leptin levels were strongly associated with subcutaneous fat area (r = 0.760) but not with intraabdominal fat. In line with these analyses, when LIS and LIR subjects were matched for subcutaneous fat area, age, and gender, they had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different. Thus, accumulation of intra-abdominal fat correlates with insulin resistance, whereas subcutaneous fat deposition correlates with circulating leptin levels. We conclude that the concurrent increase in these two metabolically distinct fat compartments is a major explanation for the association between insulin resistance and elevated circulating leptin concentrations in lean and obese subjects.

Original languageEnglish (US)
Pages (from-to)1005-1015
Number of pages11
JournalDiabetes
Volume51
Issue number4
StatePublished - 2002

Fingerprint

Abdominal Subcutaneous Fat
Intra-Abdominal Fat
Leptin
Insulin Resistance
Fats
Insulin
Subcutaneous Fat
Body Fat Distribution
Adipose Tissue
Fasting
Obesity
Adiposity
Tomography
Regression Analysis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : Distinct metabolic effects of two fat compartments. / Cnop, Miriam; Landchild, Melinda J.; Vidal, Josep; Havel, Peter J; Knowles, Negar G.; Carr, Darcy R.; Wang, Feng; Hull, Rebecca L.; Boyko, Edward J.; Retzlaff, Barbara M.; Walden, Carolyn E.; Knopp, Robert H.; Kahn, Steven E.

In: Diabetes, Vol. 51, No. 4, 2002, p. 1005-1015.

Research output: Contribution to journalArticle

Cnop, M, Landchild, MJ, Vidal, J, Havel, PJ, Knowles, NG, Carr, DR, Wang, F, Hull, RL, Boyko, EJ, Retzlaff, BM, Walden, CE, Knopp, RH & Kahn, SE 2002, 'The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments', Diabetes, vol. 51, no. 4, pp. 1005-1015.
Cnop, Miriam ; Landchild, Melinda J. ; Vidal, Josep ; Havel, Peter J ; Knowles, Negar G. ; Carr, Darcy R. ; Wang, Feng ; Hull, Rebecca L. ; Boyko, Edward J. ; Retzlaff, Barbara M. ; Walden, Carolyn E. ; Knopp, Robert H. ; Kahn, Steven E. / The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : Distinct metabolic effects of two fat compartments. In: Diabetes. 2002 ; Vol. 51, No. 4. pp. 1005-1015.
@article{8ec0454cead34cb29074204dc9fd352b,
title = "The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments",
abstract = "Obesity is associated with insulin resistance, particularly when body fat has a central distribution. However, insulin resistance also frequently occurs in apparently lean individuals. It has been proposed that these lean insulin-resistant individuals have greater amounts of body fat than lean insulin-sensitive subjects. Alternatively, their body fat distribution may be different. Obesity is associated with elevated plasma leptin levels, but some studies have suggested that insulin sensitivity is an additional determinant of circulating leptin concentrations. To examine how body fat distribution contributes to insulin sensitivity and how these variables are related to leptin levels, we studied 174 individuals (73 men, 101 women), a priori classified as lean insulin-sensitive (LIS, n = 56), lean insulin-resistant (LIR, n = 61), and obese insulin-resistant (OIR, n = 57) based on their BMI and insulin sensitivity index (SI). Whereas the BMI of the two lean groups did not differ, the SI of the LIR subjects was less than half that of the LIS group. The subcutaneous and intra-abdominal fat areas, determined by computed tomography, were 45 and 70{\%} greater in the LIR subjects (P < 0.001) and 2.5- and 3-fold greater in the OIR group, as compared with the LIS group. Fasting plasma leptin levels were moderately increased in LIR subjects (10.8 ± 7.1 vs. 8.1 ± 6.4 ng/ml in LIS subjects; P < 0.001) and doubled in OIR subjects (21.9 ± 15.5 ng/ml; P < 0.001). Because of the confounding effect of body fat, we examined the relationships between adiposity, insulin sensitivity, and leptin concentrations by multiple regression analysis. Intraabdominal fat was the best variable predicting insulin sensitivity in both genders and explained 54{\%} of the variance in SI. This inverse relationship was nonlinear (r = -0.688). On the other hand, in both genders, fasting leptin levels were strongly associated with subcutaneous fat area (r = 0.760) but not with intraabdominal fat. In line with these analyses, when LIS and LIR subjects were matched for subcutaneous fat area, age, and gender, they had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different. Thus, accumulation of intra-abdominal fat correlates with insulin resistance, whereas subcutaneous fat deposition correlates with circulating leptin levels. We conclude that the concurrent increase in these two metabolically distinct fat compartments is a major explanation for the association between insulin resistance and elevated circulating leptin concentrations in lean and obese subjects.",
author = "Miriam Cnop and Landchild, {Melinda J.} and Josep Vidal and Havel, {Peter J} and Knowles, {Negar G.} and Carr, {Darcy R.} and Feng Wang and Hull, {Rebecca L.} and Boyko, {Edward J.} and Retzlaff, {Barbara M.} and Walden, {Carolyn E.} and Knopp, {Robert H.} and Kahn, {Steven E.}",
year = "2002",
language = "English (US)",
volume = "51",
pages = "1005--1015",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations

T2 - Distinct metabolic effects of two fat compartments

AU - Cnop, Miriam

AU - Landchild, Melinda J.

AU - Vidal, Josep

AU - Havel, Peter J

AU - Knowles, Negar G.

AU - Carr, Darcy R.

AU - Wang, Feng

AU - Hull, Rebecca L.

AU - Boyko, Edward J.

AU - Retzlaff, Barbara M.

AU - Walden, Carolyn E.

AU - Knopp, Robert H.

AU - Kahn, Steven E.

PY - 2002

Y1 - 2002

N2 - Obesity is associated with insulin resistance, particularly when body fat has a central distribution. However, insulin resistance also frequently occurs in apparently lean individuals. It has been proposed that these lean insulin-resistant individuals have greater amounts of body fat than lean insulin-sensitive subjects. Alternatively, their body fat distribution may be different. Obesity is associated with elevated plasma leptin levels, but some studies have suggested that insulin sensitivity is an additional determinant of circulating leptin concentrations. To examine how body fat distribution contributes to insulin sensitivity and how these variables are related to leptin levels, we studied 174 individuals (73 men, 101 women), a priori classified as lean insulin-sensitive (LIS, n = 56), lean insulin-resistant (LIR, n = 61), and obese insulin-resistant (OIR, n = 57) based on their BMI and insulin sensitivity index (SI). Whereas the BMI of the two lean groups did not differ, the SI of the LIR subjects was less than half that of the LIS group. The subcutaneous and intra-abdominal fat areas, determined by computed tomography, were 45 and 70% greater in the LIR subjects (P < 0.001) and 2.5- and 3-fold greater in the OIR group, as compared with the LIS group. Fasting plasma leptin levels were moderately increased in LIR subjects (10.8 ± 7.1 vs. 8.1 ± 6.4 ng/ml in LIS subjects; P < 0.001) and doubled in OIR subjects (21.9 ± 15.5 ng/ml; P < 0.001). Because of the confounding effect of body fat, we examined the relationships between adiposity, insulin sensitivity, and leptin concentrations by multiple regression analysis. Intraabdominal fat was the best variable predicting insulin sensitivity in both genders and explained 54% of the variance in SI. This inverse relationship was nonlinear (r = -0.688). On the other hand, in both genders, fasting leptin levels were strongly associated with subcutaneous fat area (r = 0.760) but not with intraabdominal fat. In line with these analyses, when LIS and LIR subjects were matched for subcutaneous fat area, age, and gender, they had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different. Thus, accumulation of intra-abdominal fat correlates with insulin resistance, whereas subcutaneous fat deposition correlates with circulating leptin levels. We conclude that the concurrent increase in these two metabolically distinct fat compartments is a major explanation for the association between insulin resistance and elevated circulating leptin concentrations in lean and obese subjects.

AB - Obesity is associated with insulin resistance, particularly when body fat has a central distribution. However, insulin resistance also frequently occurs in apparently lean individuals. It has been proposed that these lean insulin-resistant individuals have greater amounts of body fat than lean insulin-sensitive subjects. Alternatively, their body fat distribution may be different. Obesity is associated with elevated plasma leptin levels, but some studies have suggested that insulin sensitivity is an additional determinant of circulating leptin concentrations. To examine how body fat distribution contributes to insulin sensitivity and how these variables are related to leptin levels, we studied 174 individuals (73 men, 101 women), a priori classified as lean insulin-sensitive (LIS, n = 56), lean insulin-resistant (LIR, n = 61), and obese insulin-resistant (OIR, n = 57) based on their BMI and insulin sensitivity index (SI). Whereas the BMI of the two lean groups did not differ, the SI of the LIR subjects was less than half that of the LIS group. The subcutaneous and intra-abdominal fat areas, determined by computed tomography, were 45 and 70% greater in the LIR subjects (P < 0.001) and 2.5- and 3-fold greater in the OIR group, as compared with the LIS group. Fasting plasma leptin levels were moderately increased in LIR subjects (10.8 ± 7.1 vs. 8.1 ± 6.4 ng/ml in LIS subjects; P < 0.001) and doubled in OIR subjects (21.9 ± 15.5 ng/ml; P < 0.001). Because of the confounding effect of body fat, we examined the relationships between adiposity, insulin sensitivity, and leptin concentrations by multiple regression analysis. Intraabdominal fat was the best variable predicting insulin sensitivity in both genders and explained 54% of the variance in SI. This inverse relationship was nonlinear (r = -0.688). On the other hand, in both genders, fasting leptin levels were strongly associated with subcutaneous fat area (r = 0.760) but not with intraabdominal fat. In line with these analyses, when LIS and LIR subjects were matched for subcutaneous fat area, age, and gender, they had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different. Thus, accumulation of intra-abdominal fat correlates with insulin resistance, whereas subcutaneous fat deposition correlates with circulating leptin levels. We conclude that the concurrent increase in these two metabolically distinct fat compartments is a major explanation for the association between insulin resistance and elevated circulating leptin concentrations in lean and obese subjects.

UR - http://www.scopus.com/inward/record.url?scp=0036228581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036228581&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 1005

EP - 1015

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -